Research Article
PDF Zotero Mendeley EndNote BibTex Cite

TEKNOLOJİK PATENT, FİNANSAL DERİNLEŞME VE SAĞLIK HARCAMALARI ARASINDAKİ İLİŞKİNİN SAPTANMASI

Year 2021, Volume 0, Issue 12, 18 - 38, 30.04.2021
https://doi.org/10.29157/etusbed.795453

Abstract

Bu araştırmada sağlık hizmetleri sektörünün finansmanı ve teknolojik inovasyon alanında yaşanan gelişim arasında bir bağlantı olup olmadığı incelenmiştir. Başka bir ifadeyle değişkenler arasındaki karşılıklı ilişki araştırılmıştır. Bu amaçla 83 gelişmiş ve gelişmekte olan ülkenin 2002-2018 dönemi, iki aşamalı Sistem-GMM yöntemi uygulanarak analiz edilmiştir. Analiz sonuçlarına göre hem sağlık harcamalarının hem de teknolojik inovasyonun birbirleri üzerindeki etkisi pozitif yönlü ve anlamlıdır. Sonuçlar, sağlık harcamalarında yaşanan artışların teknolojik inovasyonu teşvik ettiğini göstermiştir. Aynı zamanda, teknolojik inovasyona yapılan harcamalar sağlık hizmetleri sektörüne yapılan harcamaları arttırmıştır. Araştırmada ayrıca, sağlık hizmetleri sektörüne yapılan harcamaların inovasyon üzerindeki etkisinde finansal derinleşmenin düzenleyici bir etkisi olup olmadığı araştırılmıştır. Sonuçlar, söz konusu moderatör etkinin düşük de olsa olduğunu ve de bu etkinin pozitif yönlü olduğunu ortaya çıkarmıştır. Buna göre, finansal gelişim ve derinleşme artıkça, sağlık harcamalarının inovasyon üzerindeki etkisi pozitif yönlü artacaktır.

References

  • Agha, L. (2014). “The Effects of Health Information Technology on The Costs and quality of medical care”, Journal of health economics, 34, 19-30.
  • Bukachi, F., & Pakenham-Walsh, N. (2007). “Information Technology for Health in Developing Countries”, Chest, 132(5), 1624-1630.
  • Chandra, R., & Dharne, S. (2016).” Innovation in Health Insurance Products Can Bring Health Care to the Billions of Uninsured”, Journal of Commerce and Management Thought, 7(1), 163-170.
  • Goddeeris, J. H. (2001). “Insurance and Incentives for Innovation in Medical Care”, Southern Economic Journal, 530-539.
  • Ilinca, S., Hamer, S., Botje, D., Espin, J., Mendes, R. V., Mueller, J., ... & Plochg, T. (2012). “All You Need to Know About Innovation in Healthcare: The 10 Best Reads”, International Journal of Healthcare Management, 5(4), 193-202.
  • Krieger, J., Li, D., & Papanikolaou, D. (2018). “Missing Novelty in Drug Development”, NBER Working Paper, (w24595).
  • Leonard, E., De Kock, I. H., & Bam, W. (2019). “The Development of A Healthcare İnnovation Adoption Readiness Assessment Tool (HIARAT)”, South African Journal of Industrial Engineering, 30(1), 147-170.
  • Lichtenberg, F. (1996). “The Effect of Pharmaceutical Utilisation and Innovation on Hospitalisation and Mortality”, In Productivity, Technology and Economic Growth ( 317-344). Springer, Boston, MA.
  • Lichtenberg, F. R. (2001). “Are The Benefits of Newer Drugs worth Their Cost? Evidence from the 1996 MEPS”, Health Affairs, 20(5), 241-251.
  • Lichtenberg, F. R. (2007). “Benefits and costs of newer drugs: an update”, Managerial and Decision Economics, 28(4‐5), 485-490.
  • Lichtenberg, F. R. (2013). “The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from The 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files”, In Forum for Health Economics and Policy (16 (1), 1-33). De Gruyter.
  • Lichtenberg, F. R. (2015). “The Impact of Biomedical Innovation on Longevity and Health”, Nordic Journal of Health Economics, 5(1), pp-45.
  • Lichtenberg, F. R. (2015). “The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000–2011”, International journal of health economics and management, 15(3), 339-359.
  • Lichtenberg, F. R. (2016). “The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Switzerland, 1995–2012”, The European Journal of Health Economics, 17(7), 833-854.
  • Lichtenberg, F. R., & Hostenkamp, G. (2013). “The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: US and International Evidence”, CESifo Working Paper Series, 4516
  • Liu, Y. M., & Hsieh, C. R. (2012). “New Drugs and The Growth of Health Expenditure: Evidence from Diabetic Patients in Taiwan”, Health Economics, 21(5), 496-513.
  • Marsch, L. A., & Gustafson, D. H. (2013). “The Role of Technology in Health Care İnnovation: A Commentary”, Journal of Dual Diagnosis, 9(1), 101-103.
  • Okunade, A. A., & Osmani, A. R. (2018).” Technology, Productivity and Costs in Healthcare”, Oxford Research Encyclopedia of Economics and Finance, Oxford University Press, Oxford, 1-21
  • Omachonu, V. K., & Einspruch, N. G. (2010). “Innovation in Healthcare Delivery Systems: A Conceptual Framework”, The Innovation Journal: The Public Sector Innovation Journal, 15(1), 1-20.
  • Rouse, W. B. (2009). “Engineering Perspectives on Healthcare Delivery: Can We Afford Technological İnnovation in Healthcare?”, Systems Research and Behavioral Science: The Official Journal of the International Federation for Systems Research, 26(5), 573-582.
  • Serova, E., & Guryeva, I. (2018). “Health Care Information Technologies Innovation”, ECMLG 2018 14th European Conference on Management, Leadership and Governance (p. 245). Academic Conferences and publishing limited.
  • Shekelle, P. G., Ortiz, E., Newberry, S. J., Rich, M. W., Rhodes, S. L., Brook, R. H., & Goldman, D. P. (2005). “Identifying Potential Health Care Innovations for The Future Elderly: Prospects for Advances İn Medical Research And Technology İn The First Part Of The Twenty-First Century”, Health Affairs, 24(Suppl2), W5-R67.
  • Smith, S. D., Heffler, S. K., & Freeland, M. S. (2000). “The Impact of Technological Change on Health Care Cost Spending: An Evaluation of The Literatüre”, Washington, DC: Health Care Financing Administration.
  • Shah, M.B. (2000), "Effect of Pharmaceutical Innovation on Health Care Utilization and Expenditure", Doctor of Pharmacy Mercer Univeristy, School of Pharmacy, Yayımlanmamış Doktora Tezi, 1-129.
  • Sorenson, C., Drummond, M., & Khan, B. B. (2013). “Medical Technology As A Key Driver of Rising Health Expenditure: Disentangling The Relationship”, ClinicoEconomics and outcomes research: CEOR, 5, 223.
  • Wass, S., Carlsson, B., Vimarlund, V., Korkmaz, S., Shemeikka, T., & Vég, A. (2015). “Exploring The Effects of Ehealth Service İnnovation”, Health Systems, 4(3), 212-223.
  • Witjas-Paalberends, E. R., van Laarhoven, L. P. M., van de Burgwal, L. H. M., Feilzer, J., de Swart, J., Claassen, E., & Jansen, W. T. M. (2018). “Challenges and Best Practices for Big Data-Driven Healthcare İnnovations Conducted By Profit–Non-Profit Partnerships–A Quantitative Prioritization”, International Journal of Healthcare Management, 11(3), 171-181.
  • Tekin Z., Gurlaş F., Karakuş K. ve Akyol H. (2019). “Teknolojik İnovasyon ve Girişimciliğin Sağlık Finansmanı ile Olan İlişkisi Nedir?”, 4. Uluslararası Sağlık Bilimleri ve Yönetim Kongresi, 20-23 Haziran 2019, Üsküdar Üniversitesi, İstanbul.

Year 2021, Volume 0, Issue 12, 18 - 38, 30.04.2021
https://doi.org/10.29157/etusbed.795453

Abstract

References

  • Agha, L. (2014). “The Effects of Health Information Technology on The Costs and quality of medical care”, Journal of health economics, 34, 19-30.
  • Bukachi, F., & Pakenham-Walsh, N. (2007). “Information Technology for Health in Developing Countries”, Chest, 132(5), 1624-1630.
  • Chandra, R., & Dharne, S. (2016).” Innovation in Health Insurance Products Can Bring Health Care to the Billions of Uninsured”, Journal of Commerce and Management Thought, 7(1), 163-170.
  • Goddeeris, J. H. (2001). “Insurance and Incentives for Innovation in Medical Care”, Southern Economic Journal, 530-539.
  • Ilinca, S., Hamer, S., Botje, D., Espin, J., Mendes, R. V., Mueller, J., ... & Plochg, T. (2012). “All You Need to Know About Innovation in Healthcare: The 10 Best Reads”, International Journal of Healthcare Management, 5(4), 193-202.
  • Krieger, J., Li, D., & Papanikolaou, D. (2018). “Missing Novelty in Drug Development”, NBER Working Paper, (w24595).
  • Leonard, E., De Kock, I. H., & Bam, W. (2019). “The Development of A Healthcare İnnovation Adoption Readiness Assessment Tool (HIARAT)”, South African Journal of Industrial Engineering, 30(1), 147-170.
  • Lichtenberg, F. (1996). “The Effect of Pharmaceutical Utilisation and Innovation on Hospitalisation and Mortality”, In Productivity, Technology and Economic Growth ( 317-344). Springer, Boston, MA.
  • Lichtenberg, F. R. (2001). “Are The Benefits of Newer Drugs worth Their Cost? Evidence from the 1996 MEPS”, Health Affairs, 20(5), 241-251.
  • Lichtenberg, F. R. (2007). “Benefits and costs of newer drugs: an update”, Managerial and Decision Economics, 28(4‐5), 485-490.
  • Lichtenberg, F. R. (2013). “The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from The 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files”, In Forum for Health Economics and Policy (16 (1), 1-33). De Gruyter.
  • Lichtenberg, F. R. (2015). “The Impact of Biomedical Innovation on Longevity and Health”, Nordic Journal of Health Economics, 5(1), pp-45.
  • Lichtenberg, F. R. (2015). “The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000–2011”, International journal of health economics and management, 15(3), 339-359.
  • Lichtenberg, F. R. (2016). “The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Switzerland, 1995–2012”, The European Journal of Health Economics, 17(7), 833-854.
  • Lichtenberg, F. R., & Hostenkamp, G. (2013). “The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: US and International Evidence”, CESifo Working Paper Series, 4516
  • Liu, Y. M., & Hsieh, C. R. (2012). “New Drugs and The Growth of Health Expenditure: Evidence from Diabetic Patients in Taiwan”, Health Economics, 21(5), 496-513.
  • Marsch, L. A., & Gustafson, D. H. (2013). “The Role of Technology in Health Care İnnovation: A Commentary”, Journal of Dual Diagnosis, 9(1), 101-103.
  • Okunade, A. A., & Osmani, A. R. (2018).” Technology, Productivity and Costs in Healthcare”, Oxford Research Encyclopedia of Economics and Finance, Oxford University Press, Oxford, 1-21
  • Omachonu, V. K., & Einspruch, N. G. (2010). “Innovation in Healthcare Delivery Systems: A Conceptual Framework”, The Innovation Journal: The Public Sector Innovation Journal, 15(1), 1-20.
  • Rouse, W. B. (2009). “Engineering Perspectives on Healthcare Delivery: Can We Afford Technological İnnovation in Healthcare?”, Systems Research and Behavioral Science: The Official Journal of the International Federation for Systems Research, 26(5), 573-582.
  • Serova, E., & Guryeva, I. (2018). “Health Care Information Technologies Innovation”, ECMLG 2018 14th European Conference on Management, Leadership and Governance (p. 245). Academic Conferences and publishing limited.
  • Shekelle, P. G., Ortiz, E., Newberry, S. J., Rich, M. W., Rhodes, S. L., Brook, R. H., & Goldman, D. P. (2005). “Identifying Potential Health Care Innovations for The Future Elderly: Prospects for Advances İn Medical Research And Technology İn The First Part Of The Twenty-First Century”, Health Affairs, 24(Suppl2), W5-R67.
  • Smith, S. D., Heffler, S. K., & Freeland, M. S. (2000). “The Impact of Technological Change on Health Care Cost Spending: An Evaluation of The Literatüre”, Washington, DC: Health Care Financing Administration.
  • Shah, M.B. (2000), "Effect of Pharmaceutical Innovation on Health Care Utilization and Expenditure", Doctor of Pharmacy Mercer Univeristy, School of Pharmacy, Yayımlanmamış Doktora Tezi, 1-129.
  • Sorenson, C., Drummond, M., & Khan, B. B. (2013). “Medical Technology As A Key Driver of Rising Health Expenditure: Disentangling The Relationship”, ClinicoEconomics and outcomes research: CEOR, 5, 223.
  • Wass, S., Carlsson, B., Vimarlund, V., Korkmaz, S., Shemeikka, T., & Vég, A. (2015). “Exploring The Effects of Ehealth Service İnnovation”, Health Systems, 4(3), 212-223.
  • Witjas-Paalberends, E. R., van Laarhoven, L. P. M., van de Burgwal, L. H. M., Feilzer, J., de Swart, J., Claassen, E., & Jansen, W. T. M. (2018). “Challenges and Best Practices for Big Data-Driven Healthcare İnnovations Conducted By Profit–Non-Profit Partnerships–A Quantitative Prioritization”, International Journal of Healthcare Management, 11(3), 171-181.
  • Tekin Z., Gurlaş F., Karakuş K. ve Akyol H. (2019). “Teknolojik İnovasyon ve Girişimciliğin Sağlık Finansmanı ile Olan İlişkisi Nedir?”, 4. Uluslararası Sağlık Bilimleri ve Yönetim Kongresi, 20-23 Haziran 2019, Üsküdar Üniversitesi, İstanbul.

Details

Primary Language Turkish
Subjects Social Sciences, Interdisciplinary
Journal Section Research Article
Authors

Hikmet AKYOL (Primary Author)
Gümüşhane Ünivesitesi Şiran Mustafa Beyaz Meslek Yüksek Okulu
0000-0001-9119-7416
Türkiye


Fevziye GURLAŞ
Gümüşhane Üniversitesi
0000-0003-1692-4294
Türkiye

Publication Date April 30, 2021
Published in Issue Year 2021, Volume 0, Issue 12

Cite

APA Akyol, H. & Gurlaş, F. (2021). TEKNOLOJİK PATENT, FİNANSAL DERİNLEŞME VE SAĞLIK HARCAMALARI ARASINDAKİ İLİŞKİNİN SAPTANMASI . Erzurum Teknik Üniversitesi Sosyal Bilimler Enstitüsü Dergisi , 0 (12) , 18-38 . DOI: 10.29157/etusbed.795453